Evidence map›Paper›PMID 40226465›Full record

ArticleAmerican journal of cancer research2025

The impact of behavioral activation on depressive symptoms in colorectal cancer patients within a medical environment: the mediating role of physical activity.

Anlong Li, Han Ge, Runze Huang, Dajie Liu, Shaochun Liu, Yingxue Jia, Jiaying Chai, Xinyi Zheng, Lijun Liu, Chen Gan and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in American journal of cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06348940 (Effects of Behavioral Activation on Negative Emotions, Cancer-related Symptoms and Clinical Indicators in Cancer Patients), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06348940 naactive not recruitingnot on this map

Effects of Behavioral Activation on Negative Emotions, Cancer-related Symptoms and Clinical Indicators in Cancer Patients

TypeinterventionalSponsorAnhui Medical UniversityRan2023 to 2024Enrolled600ConditionsCancer PatientsArmsbehavioral activation
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anlong LiDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.
Han GeDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.
Runze HuangDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.
Dajie LiuDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.
Shaochun LiuDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.
Yingxue JiaDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.
Jiaying ChaiDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.
Xinyi ZhengThe Third School of Clinical Medicine, Southern Medical University Guangzhou 510500, Guangdong, PR China.
Lijun LiuDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.
Chen GanDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.
Jian XuDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.
Ling ChengDepartment of Oncology, Shenzhen Hospital of Guangzhou University of Chinese Medicine (Futian) Shenzhen 518000, Guangdong, PR China.
Mingjun ZhangDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.
Huaidong ChengDepartment of Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei 230601, Anhui, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) treatment often affects patients' quality of life, leading to depressive symptoms. Behavioral activation (BA) therapy, which increases engagement by enhancing positive reinforcement and reducing avoidance, has shown potential in managing these symptoms. Physical activity (PA) is also known to alleviate depression, though its role as a mediator in BA's effectiveness remains unclear. This clinical trial was retrospectively registered in ClinicalTrials.gov on April 5, 2024 (Effects of Behavioral Activation on Negative Emotions, Cancer-related Symptoms and Clinical Indicators in Cancer Patients, NCT06348940). This study explores PA's mediating effect within BA interventions. A total of 109 CRC patients with depressive symptoms were randomly assigned to a BA group (n=52) or a Usual Care (UC) group (n=57). Assessments occurred at baseline (T0), after the fourth session (T1), and post-intervention (T2). The BA group showed significant improvement compared to the UC group. Repeated measures ANOVA confirmed BA's effectiveness in reducing depressive symptoms, improving quality of life, alleviating psychological distress, increasing activation, and raising PA levels. PA changes accounted for 36.91% of the intervention's total effect on depression reduction. BA effectively reduces depression and enhances life quality in CRC patients. Changes in PA intensity are significantly associated with depression reduction, suggesting PA's mediating role in BA's impact. Incorporating PA into BA may enhance therapeutic outcomes for CRC patients with depression.

Indexed as

Behavioral activationcolorectal cancerdepressionphysical activityquality of life

Identifiers

PMID40226465
PMCPMC11982709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.